Search

STAAR Surgical Co

Gesloten

SectorGezondheidszorg

23.42 -3.26

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

23.42

Max

23.73

Belangrijke statistieken

By Trading Economics

Inkomsten

5.2M

5.2M

Verkoop

36M

94M

EPS

0.29

Winstmarge

5.567

Werknemers

921

EBITDA

19M

10M

Aanbevelingen

By TipRanks

Aanbevelingen

Neutraal

12 Maanden Prognose

+34% upside

Dividenden

By Acuity

Volgende Winsten

12 aug 2026

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-192M

1.2B

Vorige openingsprijs

26.68

Vorige sluitingsprijs

23.42

Nieuwssentiment

By Acuity

53%

47%

268 / 340 Rangschikking in Healthcare

STAAR Surgical Co Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

22 jul 2026, 18:11 UTC

News

Wedbush reiterated its OUTPERFORM rating on STAAR Surgical, maintaining a $40 price target, contributing to shares trading higher today.

21 jul 2026, 16:56 UTC

Social Media

STAAR Surgical preannounces second-quarter revenue over $90 million, up from $44.3 million last year, as shares gain amid market volatility.

20 jul 2026, 20:01 UTC

News

STAAR Surgical shares are lower amid investor concerns over sustainability despite projected Q2 sales exceeding $90 million and strong growth in China and the Americas.

Peer Vergelijking

Prijswijziging

STAAR Surgical Co Prognose

Koersdoel

By TipRanks

34% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 31.33 USD  34%

Hoogste 40 USD

Laagste 25 USD

Gebaseerd op 8 Wall Street-analisten die 12-maands prijsdoelen bieden voor STAAR Surgical Co - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Neutraal

8 ratings

2

Buy

6

Hold

0

Sell

Sentiment

By Acuity

268 / 340 Rangschikking in Gezondheidszorg

Nieuwssentiment

Bullish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Onder gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over STAAR Surgical Co

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.
help-icon Live chat